Veradermics, Incorporated (MANE) News
Follow Veradermics, Incorporated (MANE) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 11 public stories across 7 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
M
Veradermics Reports Positive 12-Month Phase 3 Data in Male Pattern Hair Loss
EQUITY | Nov 09, 2026, 12:09 PM UTC
L
Veradermics Shares Rise After Positive VDPHL01 Phase 3 Trial Data
The company reported positive top-line results from Part A of a placebo-controlled Phase 3 trial of its oral minoxidil formulation in more than 500 males.
EQUITY | Oct 19, 2026, 02:29 PM UTC
M
Veradermics Says Oral Hair-Loss Drug Boosted Growth in Late-Stage Study
Veradermics said its oral pill helped increase hair growth in men with pattern hair loss in a late-stage study. Shares rose 7.5% to $117 in premarket trading.
EQUITY | Oct 19, 2026, 01:19 PM UTC
M
Veradermics Reports Positive Phase 3 VDPHL01 Topline Results
Veradermics said VDPHL01 produced hair-count increases of up to 36.4 hairs/cm², with no treatment-related serious adverse events.
EQUITY | Oct 19, 2026, 01:13 PM UTC
H
Helen Of Troy Posts Upbeat Q2 Earnings, Joins Pacira Biosciences, Wolfspeed And Other Big Stocks Moving Higher On Thursday
U.S. stocks were lower, with the Nasdaq Composite falling around 100 points on Thursday. Shares of Helen of Troy Limited (NASDAQ: HELE ) rose sharply after the company reported better-than-expected second-quarter adjuste
LIVE | Oct 08, 2026, 01:53 PM UTC
L
MANE: Key clinical trials may soon deliver the first FDA-approved oral hair loss treatment for both genders
Upcoming clinical data will evaluate an extended-release oral minoxidil for pattern hair loss, aiming to provide the first FDA-approved oral treatment for both males and females. Trials show rapid, robust efficacy and st
REGULATION | Sep 09, 2026, 07:39 PM UTC
L
MANE - Veradermics to Present at Upcoming September Investor Conferences
MANE - Veradermics to Present at Upcoming September Investor Conferences
EQUITY | Sep 03, 2026, 09:41 PM UTC
L
Veradermics management to present at September investor conferences
Veradermics (NYSE: MANE) said management will participate in upcoming investor conferences in September. Details beyond the September schedule were not provided in the excerpt.
EQUITY | Sep 03, 2026, 09:33 PM UTC
L
Veradermics Q2 EPS Beats Estimate
Veradermics reports Q2 EPS of $(0.58), beating the $(0.65) estimate
EARNINGS | Aug 11, 2026, 08:54 PM UTC
H
Sector Update: Healthcare Stocks Advance Late Afternoon
() -- Healthcare stocks rose late Wednesday afternoon, with the NYSE Healthcare Index adding 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) increasing 0.1%. The iShares Biotechnology ETF (IBB) added 0
EARNINGS | Jul 15, 2026, 07:47 PM UTC
H
PayPal, Veradermics, Alibaba And Other Big Stocks Moving Higher On Wednesday
U.S. stocks were higher, with the Dow Jones index gaining around 100 points on Wednesday. Shares of PayPal Holdings Inc (NASDAQ: PYPL ) rose sharply following a report that Stripe and Advent International have proposed a
RATES | Jul 15, 2026, 01:56 PM UTC